Epic Bio takes aim at DUX4
Posted on October 28th, 202210/28/22
Updated 12-12-24 to reflect the chance in name from Epic Bio to Epicrispr Biotechnologies. Leading-edge CRISPR biotech chooses FSHD as its first disease target Epicrispr Biotechnologies, based in the San […]
Filed under: FSHD Research